KUALA LUMPUR: After finding clauses deemed unfavourable to the government and more in favour of the supplier, the Attorney General’s Chambers (AGC) proposed for amendments to be made in Malaysia’s vaccine procurement agreement with Pfizer (Malaysia) Sdn Bhd.
This was revealed in the White Paper on Covid-19 Vaccine Procurement Management released in Parliament yesterday.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
